Condition: Diabetic Kidney Disease · Diabetic Nephropathies · Sponsor: Ain Shams University
The goal of this controlled, randomized, clinical trial is to evaluate the effect of vinpocetine on clinical outcomes on the diabetic nephropathy patients. The following will be evaluated; anthropometrics, kidney functions, glucose panel, lipid panel, ICAM-1, quality of life. Participants will receive either vinpocetine or placebo, twice daily for 3 months.
This description comes directly from the study's public registry record.
Tamer El Said · 201227366062 · drtamer_elsaid@med.asu.edu.eg
Always discuss trial participation with your own doctor first.
| Ain Shams University Hospital | Cairo, Abbasseia, Egypt | Not Yet Recruiting |
| Ain Shams Hospitals | Cairo, Abbasseya, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06441591